Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | COMMODORE CAPITAL LP | 1,831,746 3.500% | 1,831,746 (New Position) | Filing History |
| 2024-02-14 07:02 am Purchase | 2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | RTW INVESTMENTS LP | 9,220,672 9.990% | 9,220,672 (New Position) | Filing History |
| 2024-02-14 06:28 am Sale | 2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | Radcliffe Capital Management L.P. | 0 0.000% | -62,756 (Position Closed) | Filing History |
| 2023-12-04 4:33 pm Purchase | 2023-11-22 | 13G | SAB Biotherapeutics, Inc. SABS | BIOTECHNOLOGY VALUE FUND L P | 917,828 9.990% | 917,828 (New Position) | Filing History |
| 2023-10-16 4:05 pm Purchase | 2023-10-04 | 13G | SAB Biotherapeutics, Inc. SABS | COMMODORE CAPITAL LP | 693,246 9.900% | 693,246 (New Position) | Filing History |
| 2022-12-16 4:33 pm Purchase | 2022-12-07 | 13D | SAB Biotherapeutics, Inc. SABS | HAMILTON CHRISTINE E | 871,205 17.300% | 9,880 (+1.15%) | Filing History |
| 2022-09-08 5:07 pm Purchase | 2022-09-07 | 13D | SAB Biotherapeutics, Inc. SABS | Sullivan Eddie Joe | 571,911 13.300% | 1,400 (+0.25%) | Filing History |
| 2022-09-08 5:04 pm Sale | 2022-06-07 | 13D | SAB Biotherapeutics, Inc. SABS | HAMILTON CHRISTINE E | 861,324 20.000% | -207,274 (-19.40%) | Filing History |
| 2022-05-27 4:24 pm Sale | 2022-05-20 | 13D | SAB Biotherapeutics, Inc. SABS | Big Cypress Holdings LLC | 96,530 2.200% | -208,403 (-68.34%) | Filing History |
| 2022-02-14 06:09 am Purchase | 2021-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | Radcliffe Capital Management L.P. | 62,756 1.440% | 62,756 (New Position) | Filing History |
| 2022-02-11 3:39 pm Unchanged | 2021-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | BASSO CAPITAL MANAGEMENT L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-11-01 7:38 pm Purchase | 2021-10-22 | 13D | SAB Biotherapeutics, Inc. SABS | Big Cypress Holdings LLC | 304,933 7.000% | 304,933 (New Position) | Filing History |
| 2021-11-01 4:57 pm Purchase | 2021-10-22 | 13D | SAB Biotherapeutics, Inc. SABS | HAMILTON CHRISTINE E | 1,068,598 24.580% | 1,068,598 (New Position) | Filing History |
| 2021-11-01 4:55 pm Purchase | 2021-10-22 | 13D | SAB Biotherapeutics, Inc. SABS | Sullivan Eddie Joe | 570,511 13.120% | 570,511 (New Position) | Filing History |
| 2021-10-19 09:51 am Purchase | 2021-10-13 | 13G | Big Cypress Acquisition Corp. BCYP | Radcliffe Capital Management L.P. | 1,296,891 8.770% | 1,296,891 (New Position) | Filing History |
| 2021-02-24 10:00 am Purchase | 2021-02-22 | 13G | Big Cypress Acquisition Corp. BCYP | BASSO CAPITAL MANAGEMENT L.P. | 757,794 5.120% | 757,794 (New Position) | Filing History |